These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32937809)

  • 21. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.
    Jang JY; Park T; Lee S; Kang MJ; Lee SY; Lee KB; Chang YR; Kim SW
    Br J Surg; 2014 May; 101(6):686-92. PubMed ID: 24668442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
    Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched-duct and mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Iwaya H; Hijioka S; Mizuno N; Kuwahara T; Okuno N; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Ito A; Kuraoka N; Matsumoto S; Polmanee P; Shimizu Y; Yatabe Y; Niwa Y; Tamada K; Ido A; Hara K
    Dig Endosc; 2019 Nov; 31(6):672-681. PubMed ID: 30920028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.
    Robles EP; Maire F; Cros J; Vullierme MP; Rebours V; Sauvanet A; Aubert A; Dokmak S; Lévy P; Ruszniewski P
    United European Gastroenterol J; 2016 Aug; 4(4):580-6. PubMed ID: 27536368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
    Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
    J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
    Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
    Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.
    Balduzzi A; Marchegiani G; Pollini T; Biancotto M; Caravati A; Stigliani E; Burelli A; Bassi C; Salvia R
    Pancreatology; 2021 May; ():. PubMed ID: 33994068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography.
    Koshita S; Fujita N; Noda Y; Kobayashi G; Ito K; Horaguchi J; Kanno Y; Ogawa T; Masu K; Michikawa Y; Iwashita Y; Sawai T; Uzuki M; Fujishima F
    J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):301-9. PubMed ID: 25488889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.
    Ono J; Yaeger KA; Genevay M; Mino-Kenudson M; Brugge WR; Pitman MB
    Cytojournal; 2011; 8():21. PubMed ID: 22145009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
    AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
    Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
    World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.